Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy

Ocular Immunology and Inflammation

Volumn 15, Issue 2, 2007, Pages 105-111

  Konuk, Onur ^a,b   Hondur, Ahmet ^a   Akyurek, Nalan ^a   Unal, Mehmet ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Department of Pathology ^*  (Turkey)

Author keywords

Apoptosis; Graves'; Ophthalmopathy; Orbital fibroadipose tissue

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NICK END LABELING; OPTIC NERVE DISEASE; SCORING SYSTEM; STATISTICAL ANALYSIS; TISSUE SECTION; ULTRASTRUCTURE;

ADIPOSE TISSUE; ADULT; AGED; APOPTOSIS; DISEASE PROGRESSION; FEMALE; FIBROSIS; GRAVES DISEASE; HUMANS; IN SITU NICK-END LABELING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; ORBIT; SEVERITY OF ILLNESS INDEX;

EID: 34250170108     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940601186735     Document Type: Article

References (21)

1. Heufelder AE, Bahn RS. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest. 1992;22:529-537.
2. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993;14:747-793.
3. Sorisky A, Pardasani D, Gagnon A, Smith TJ. Evidence of adipocyte differentiation in human orbital fibroblast in primary culture. J Clin Endocrinol Metab. 1996;81:3428-3431.
4. Heufelder AE. Retro-orbital autoimmunity. Bailliere's Clin Endocrinol Metab. 1997;11:499-520.
5. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
6. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
7. Nagata S. Apoptosis by death factor. Cell. 1997;88:355-365.
8. Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94:695-698.
9. Eguchi K. Apoptosis in autoimmune diseases. Intern Med. 2001;40:275-284.
10. Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE, Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first Europian Group on Graves Orbitopathy experience. Eur J Endocrinol. 2003;148:491-495.
11. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol. 1997;47:9-14.
12. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab. 1973;37:276-285.
13. Nunery WR,Martin RT, Heinz GW, et al. The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthal Plast Reconstr Surg. 1993;9:7714.
14. Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord. 2000;1:87-95.
15. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
16. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 1997;275:960-963.
17. Koga M, Hiromatsu Y, Jimi A, Inoue Y, Nonaka K. Possible involvement of Fas mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy. Thyroid. 1998;8:311-318.
18. Kumar S, Bahn RS. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 2003;88:4246-4250
19. Gerding MN, Prummel MF, Wiersinga WM. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters. Clin Endocrinol. 2000;52:641-646.
20. Bartelena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F, Loviselli A, Pinchera A. More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest. 1989;12:733-737.
21. Bartelena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168-199.